Impact of diabetes mellitus on one-year outcomes of bioresorbable versus durable polymer drug-eluting stents in patients undergoing percutaneous coronary intervention following rotational atherectomy: Results from a large prospective registry
Matthew Siano(Mount Sinai Medical Center), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Annapoorna Kini(Mount Sinai Medical Center), Parasuram Krishnamoorthy(Einstein Medical Center Philadelphia), Manish Vinayak(Icahn School of Medicine at Mount Sinai), Roxana Mehran(Mount Sinai Hospital), Pooja Vijay(Mount Sinai Medical Center), George Dangas(Cardiovascular Institute of the South), Rakhee R Makhija(Mount Sinai Hospital), David Power(Cardiovascular Institute of the South), Frank Kalaba(Mount Sinai Hospital), Serdar Farhan(Mount Sinai Hospital), Wen-Hsin Chang(Cardiovascular Institute of the South), Neelkumar Patel(Mount Sinai Medical Center), Roja Thapi(Mount Sinai Medical Center), Anton Camaj(Columbia University Irving Medical Center), Joseph Sweeny(Mount Sinai Hospital), Vishal Dhulipala(Mount Sinai Hospital), Nikito Gurung(Mount Sinai Medical Center), Yihan Feng(Icahn School of Medicine at Mount Sinai), Amit Hooda(Mount Sinai Hospital), Keisuke Yasumura(Cardiovascular Institute of the South)
American Heart Journal Plus Cardiology Research and Practice
November 8, 2025
Cited by 0
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k